Post-thoracotomy pain Surgery
Conditions
Interventions
Patients will be randomized by double-blind simple randomization to two groups.
1. 25 patients will receive a bolus of 30 ml of 0.25% levobupivacaine followed by an infusion of 5 ml/ho
subsequently every half an hour for the next 2 hours and then 2 hourly for the next 12 hours. As soon as the patient is alert enough VAS pain score will be recorded every 2 hours
2. To
Sponsors
National Cancer Institute, Cairo University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age from 20-60 2. ASA 2 or 3 3. Undergoing elective thoracic surgery
Exclusion criteria
Exclusion criteria: 1. Refusal of the patient 2. Coagulopathy 3. Severe cardiac or renal impairment or hepatic disease 4. Known allergy to the study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain at rest and coughing, measured by VAS pain score (10 mm vertical scale from 0-10 where zero means no pain and 10 is the worst pain) every 2h in the first 24h postoperative | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Postoperative opioid consumption, recorded by staff during first 24 hours postoperative 2. Adverse effects including nausea, vomiting, hypotension and cardiac arrhythmias, recorded by staff in the first 24h postoperative | — |
Countries
Egypt
Outcome results
None listed